Search
for
Sort by
Research 601–630 of 1000+
- Distribution of SALT Scores with Ritlecitinib Treatment up to 24 months from the ALLEGRO Phase 2b/3 and Long-Term Phase 3 Clinical Studies in Alopecia Areata
- Human regulatory γδT lymphocytes as novel autoimmunity-protective cells: Lessons from alopecia areata
- ALOPECIA AREATA PROFILING SHOWS LNCRNAS REGULATE THE SUPPRESSED EXPRESSION OF KERATIN.
- Alopecia areata
- 004 Cell-based therapy may be effective in alopecia areata: Preclinical evidence that autologous, peripheral regulatory γdT cells are preventive in human ex vivo and therapeutic in human in vivo models
- Twenty nail dystrophy with alopecia areata in an atopic child
- Comparative study between fractional carbon dioxide laser versus intralesional steroids injection in treatment of alopecia areata
- An Overview of the Biology of Platelet-Rich Plasma and Microneedling as Potential Treatments for Alopecia Areata
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Growth Factors and Microneedling in Alopecia Areata: A Narrative Review
- Dermoscopic And Clinical Features Of Alopecia Areata In Pakistani Patients: A Cross-Sectional Study
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA
- Subsurface detection of hair follicles in alopecia areata using optical coherence tomography
- Olumiant® (Baricitinib)-A Newly Approved Janus Kinase Inhibitor for the Treatment of Alopecia Areata.
- Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy
- Concurrence of alopecia areata and vitiligo at the same anatomical site
- Intramuscular triamcinolone acetonide: An undervalued option for refractory alopecia areata
- CD8+ mycosis fungoides clinically masquerading as alopecia areata
- Ensemble of pre-learned deep learning model and an optimized LSTM for Alopecia Areata classification
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- 27604 Response to baricitinib in the treatment of patients with early and late onset alopecia areata in the phase 2 portion of BRAVE-AA1 randomized controlled trial
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Supplementary Material for: Nail Involvement in Refractory Pediatric Alopecia Areata: A Duration-Dependent Finding
- Supplementary Material for: Nail Involvement in Refractory Pediatric Alopecia Areata: A Duration-Dependent Finding
- Effective management of indralupta (alopecia areata) through Ayurveda: a case study
- Alopecia Areata With an FFA ‐Like Phenotype: Clinicopathologic Features and Treatment Outcomes in a Prospective Cohort
- HOLISTIC HEALING OF ALOPECIA AREATA THROUGH HOMOEOPATHY
- Timing of Initial Hair Regrowth and Clinical Trial-Defined Response Following Ritlecitinib Treatment in Patients With Alopecia Areata
- BH06 (P075) A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata